Founded in 1994
Financial data: €275M Market Cap (on 13/02/2017)
Medigene concentrates on the development of personalized T cell immunotherapies, with focus on haematological malignancies.
Lochhamer Str. 11
Labiotech UG, All Rights Reserved -
Send this to friend